Kaye Scholer Represents Uni-World in Acquisition of Vandemark Chemical
New York — Kaye Scholer recently represented Uni-World Capital as co-equity sponsor in the acquisition, together with co-equity sponsor Brightwood Capital, of VanDeMark Chemical Inc., a manufacturer of phosgene derivatives and North America's leading producer of merchant phosgene. Phosgene is a major industrial chemical used in the pharmaceutical, agricultural-chemical, polymer and fine chemical industries.
The transaction was sourced through Sidereal Capital, which also invested in the equity and will be appointing a director to the company. Brightwood provided mezzanine financing. VanDeMark’s senior management will continue to be significant equity owners in the company and remain in their current positions at the company. For further information, please see Uni-World’s official release here.
Corporate Partner Steve Koval led the Kaye Scholer team that represented Uni-World, which also included Partners Sheryl Gittlitz, Laurie Abramowitz and Jeff London, Counsel Vickie Frankenburg, Lauretta Moran, John Rynkiewicz and Mary Lou Zwick, and Associates David Menchel, David Kim, Connie Ericson, Roxanne Mintz, Brian Witkowski and Alice Huling.